JEFF PETERSON: Open Payments
NPI 1467491076 · BOTHELL, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124,839 in 246 payments from 19 companies in 2025. Trend: 2023 $197,729 · 2024 $146,205 · 2025 $124,839
Speaker / faculty: $94,286Consulting: $15,395Travel & lodging: $9,016Food & beverage: $6,133Education: $8
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 75 | $72,146 |
| UCB, Inc. | 39 | $20,908 |
| Janssen Biotech, Inc. | 25 | $9,912 |
| SOBI, INC | 18 | $7,865 |
| Lilly USA, LLC | 10 | $5,872 |
| Eli Lilly and Company | 1 | $2,725 |
| KYOWA KIRIN, INC. | 5 | $2,567 |
| Novartis Pharmaceuticals Corporation | 18 | $1,203 |
| ABBVIE INC. | 24 | $655 |
| ANI Pharmaceuticals, Inc. | 7 | $252 |
Products named: KRYSTEXXA, Bimzelx, TREMFYA, TALTZ, CRYSVITA, Cimzia, COSENTYX, RINVOQ.
Industry payments across WA — which companies pay providers there.
